Sign in

CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Vor Biopharma Inc.

Sign in to watch
Ticker
VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
811591163
Phone
617-655-6580
Business address
500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 8-K Event Shareholder vote results
  10. 8-K Event Regulation FD disclosure
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. 10-Q Report Quarterly Report
  14. EFFECT Other Notice of Effectiveness
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. UPLOAD Other SEC-generated Letter
  19. S-3 Offering Registration Statement
  20. ARS Other Annual Report to Security Holders

Page 2 of 24 · 464 filings